Akero Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akero Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $16M | 336k | 47.48 |
| 2025-06-30 | $108M | 2.0M | 53.36 |
| 2025-03-31 | $87M | 2.2M | 40.48 |
| 2024-12-31 | $10M | 372k | 27.82 |
| 2024-09-30 | $2.7M | 95k | 28.69 |
| 2024-06-30 | $1.7M | 71k | 23.46 |
| 2024-03-31 | $5.3M | 208k | 25.26 |
| 2023-12-31 | $6.2M | 266k | 23.35 |
| 2023-09-30 | $3.0M | 58k | 50.58 |
| 2023-06-30 | $1.2M | 26k | 46.69 |
| 2023-03-31 | $6.1M | 160k | 38.26 |
| 2022-12-31 | $11M | 206k | 54.80 |
| 2022-09-30 | $127k | 3.7k | 34.16 |
| 2022-06-30 | $33k | 3.5k | 9.43 |
| 2022-03-31 | $946k | 67k | 14.21 |
| 2021-12-31 | $1.2M | 57k | 21.22 |
| 2021-09-30 | $971k | 43k | 22.44 |
| 2021-06-30 | $255k | 10k | 24.73 |
| 2021-03-31 | $830k | 29k | 28.99 |
| 2020-12-31 | $158k | 6.2k | 25.64 |
| 2020-09-30 | $52k | 1.7k | 30.75 |
| 2020-06-30 | $32k | 1.5k | 22.22 |
| 2020-03-31 | $21k | 1.0k | 20.77 |
| 2019-12-31 | $72k | 3.3k | 22.08 |
| 2019-09-30 | $139k | 6.1k | 22.81 |
| 2019-06-30 | $21k | 1.1k | 18.78 |